Articles
| Open Access |
DOI: SOME RISK FACTORS FOR PROGRESSION OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE
MD.Muminov D.K. , MD, Associate Professor, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan Musayev F.T. , Tashkent Pediatric Medical Institute, Tashkent, UzbekistanAbstract
The increase in the number of methods for diagnosing COPD and their constant improvement, the need to establish an accurate diagnosis in the early stages raises the question of the urgent need for researchers to use a minimal but sufficient set of studies. The use of each subsequent method should ensure the obtaining of data that could not be established using the previous one. When comparing different methods, one should find out their limits and capabilities, advantages and disadvantages, the possibility of replacing them with less invasive ones, as well as the reliability and value of the information obtained.
Keywords
COPD, FEV1, α1-antitrypsin
References
Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report. Bethesda: GOLD; https://goldcopd.org/2024-gold-report
Bhatt SP, Sieren JC, Dransfield MT, Washko GR, Newell JD, Jr, Stinson DS. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax. 2014;69(5):409–414. doi: 10.1136/thoraxjnl-2012-202810
Buhr RG, Barjaktarevic IZ, Quibrera PM, Bateman LA, Bleecker ER, Couper DJ. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort An Observational Cohort Study. Am J Respir Crit Care Med. 2022;206(5):554–562. doi: 10.1164/rccm.202201-0094OC.
Wan ES, Balte P, Schwartz JE, Bhatt SP, Cassano PA, Couper D. Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults [published correction appears in. JAMA. 2022;327(3):286–286. doi: 10.1001/jama.2021.20939.
Celli BR, Fabbri LM, Aaron SD, Agusti A, Brook R, Criner GJ. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations The Rome Proposal. Am J Respir Crit Care Med. 2021;204(11):1251–1258.
Agusti A, Vogelmeier CF. GOLD 2024: a brief overview of key changes. J Bras Pneumol. 2023 Dec 22;49(6):e20230369.
Hata A, Schiebler ML, Lynch DA, Hatabu H. Interstitial lung abnormalities: state of the art. Radiology . 2021;301:19–34.
Menon AA, Putman RK, Sanders JL, Hino T, Hata A, Nishino M, et al. Interstitial lung abnormalities, emphysema and spirometry in smokers. Chest . 2021;161:999–1010. –
Agusti A. Biologics for COPD - Finally Here. N Engl J Med. 2023;389(3):274–275.
Hunninghake GM, Quesada-Arias LD, Carmichael NE, Martinez Manzano JM, Poli De Frías S, Baumgartner MA, et al. Interstitial lung disease in relatives of patients with pulmonary fibrosis. Am J Respir Crit Care Med . 2020;201:1240–1248.
Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(6):591–597.
Xiang Y, Luo X. Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review. Int J Chron Obstruct Pulmon Dis. 2024 Feb 29;19:567-578.
Chen YH. Interpretation of global strategy for the diagnosis, treatment, management and prevention of chronic obstructive pulmonary disease 2022 report. Chinese General Practice. 2022;25(11):1294–1304+1308.
Shi Y, Zhang J, Huang Y. Prediction of cardiovascular risk in patients with chronic obstructive pulmonary disease: a study of the national health and nutrition examination survey database. BMC Cardiovascul Disord. 2021;21(1):417.
Fletcher J, Cooper SC, Ghosh S, et al. The role of vitamin D in inflammatory bowel disease: mechanism to management. Nutrients. 2019;11(5):1019.
Recio Iglesias J, Díez-Manglano J, López García F, et al. Management of the COPD patient with comorbidities: an experts recommendation document. Int J Chronic Obstr. 2020;15:1015–1037.
Article Statistics
Copyright License
Copyright (c) 2024 MD.Muminov D.K., Musayev F.T.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.